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SUMMARY
Diabetes is a chronic metabolic disease characterized by hyperglycaemia and a num-
ber of potential complications that significantly reduce the patient’s quality of life. In this 
study, we produced an antidiabetic functional food from Tartary buckwheat fermented by 
Lactobacillus plantarum TK9 and L. paracasei TK1501. The results of an orthogonal experi-
mental design indicated that the three factors with the largest effects on the growth of L. 
plantarum TK9 and L. paracasei TK1501 in solid-state fermentation (SSF) were in the order: 
water ratio>inoculum size>time of fermentation. Under the optimal fermentation con-
ditions comprising a 1:1.5 water ratio, 24 h of SSF and a 107 CFU/g inoculum, the Tartary 
buckwheat fermented by L. plantarum TK9 and L. paracasei TK1501 yielded viable probiot-
ic counts of (2.3±0.7)·109 and (3.3±0.4)·109 CFU/g, respectively. The nutritional potential, as 
well as antioxidant and antidiabetic properties of ethanolic extracts from fermented Tartary 
buckwheat were investigated. The highest α-glucosidase inhibitory activity, with an IC50 
of 0.51 mg/mL, was present in Tartary buckwheat fermented by L. plantarum TK9. Howev-
er, Tartary buckwheat fermented by L. paracasei TK1501 had the highest dipeptidyl pepti-
dase IV (DPP-IV) inhibition, with an IC50 of 2.47 mg/mL. Therefore, fermentation by both L. 
plantarum TK9 and L. paracasei TK1501 has the potential to yield a product that can help 
regulate the levels of blood glucose as part of a diabetic diet.
Key words: Tartary buckwheat, fermentation, α-glucosidase inhibition, dipeptidyl pepti-
dase IV inhibition, antidiabetic
INTRODUCTION
Diabetes constitutes a metabolic disorder characterized by chronic hyperglycaemia 
due to either insufficient insulin production (diabetes mellitus type 1) or insulin resistance 
(diabetes mellitus type 2) (1). It is predicted that the global number of type 2 diabetes pa-
tients will exceed 300 million by 2030 (2). Dietotherapy is the most basic therapy for di-
abetes, which makes the production of food suitable for diabetics especially important. 
In recent years, there has been renewed interest in the utilization of Tartary buckwheat 
(Fagopyrum tataricum (L.) Gaertn.) due to its antihyperglycemic benefits (3). This antidia-
betic effect of Tartary buckwheat is related to its unique chemical composition (4). It was 
discovered that Tartary buckwheat possesses higher concentrations of certain bioactive 
phytochemicals than common buckwheat (5). Moreover, the total dietary fibre content of 
Tartary buckwheat seeds was found to be 26 %, with 0.54 % soluble and 24 % insoluble 
fibre (6). Furthermore, Tartary buckwheat is an important source of phenolic acids and fla-
vonoids, including p-hydroxybenzoic, protocatechuic, caffeic, chlorogenic, gallic, ferulic, 
p-coumaric, syringic and vanillic acids (7). Flavonoids are the most crucial component of 
total buckwheat polyphenols as well as the most important health-promoting factors. In 
Tartary buckwheat seeds, rutin is the major flavonoid, followed by quercetin (8). Flavonoid 
compounds have remarkable antioxidant effects, providing various health benefits such as 
antihypertensive, antidiabetic and anticancer effects (9). Tartary buckwheat is an excellent 
source of these phytochemicals, and it is in fact bitter due to its large flavonoid content. 
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Diabetes has become a major disease worldwide, and it can 
lead to serious complications, causing enormous damage to 
the quality of life and health. The main target in the treatment 
of diabetes is the control of blood glucose levels (10). Several 
contemporary classes of hypoglycaemic agents seem to pro-
vide an effective treatment for diabetes (11). Among them, in-
hibitors of dipeptidyl peptidase IV (DPP-IV) are becoming a hot 
topic in the development of new hypoglycaemic drugs (12). 
The glucagon-like peptide-1 (GLP-1) can have a longer half-life 
due to DPP-IV inhibition, and reach the threshold of glucagon 
homeostasis (1). A number of synthetic DPP-IV inhibitors have 
shown promising results in the treatment of diabetes type 2 
(13). The α-glucosidase inhibitors, being the best-tolerated an-
tidiabetics, have the main effect of reducing α-glucosidase in 
the microvilli in order to delay the absorption of glucose and 
fructose, lower the postprandial blood glucose spikes and re-
duce the requirement for insulin injections (12,14). However, 
such drugs have side effects, such as flatulence and diarrhoea, 
and there is a demand for fermented food with DPP-IV inhibi-
tory and α-glucosidase inhibitory properties for the oral treat-
ment of diabetes type 2 patients (15).
SSF has recently received much interest as an alterna-
tive to the more costly submerged fermentation (SmF) be-
cause of its potential to convert inexpensive agro-industri-
al solid residues and plant material into a variety of valuable 
products (16). This research uses Tartary buckwheat as a sub-
strate for SSF of probiotics, with the aim to increase the con-
tents of functional components as well as the nutritional and 
health-promoting value of the final product by complex met-
abolic reactions of microorganisms. Therefore, the objective 
of this study is to evaluate the effect of SSF on the chemical 
composition of Tartary buckwheat, as well as on its antioxi-
dant and antihyperglycaemic activities.
MATERIALS AND METHODS
Microorganisms and materials
The microorganisms were deposited in the China General 
Microbiological Culture Collection Center (CGMCC) in Beijing. 
The CGMCC accession number of Lactobacillus plantarum TK9 
is 11891, and that of L. paracasei TK1501 is 13130.
The Tartary buckwheat samples used in this study were 
grown in Kunming, Yunnan province, PR China, and collected 
in October 2016. The grains were cleaned and stored in the dark 
in polyethylene containers at room temperature for less than 
3 months.
Preparation of microbiological cultures
Lactobacillus plantarum TK9 and L. paracasei TK1501 were 
activated in 10 mL of De Man, Rogosa and Sharpe (MRS) broth 
(Oxoid, Basingstoke, UK) at 37 °C for 18 h, using 1 % inocula. 
The A600 nm of the resulting culture of L. plantarum TK9 was be-
tween 1.0 and 1.2, with viable counts of (3.5±0.4)·109 CFU/mL; 
and the A600 nm of L. paracasei TK1501 was between 1.4 and 1.6, 
with viable counts of (5.5±0.4)·109 CFU/mL. The cultures were 
centrifuged (GL20A, Xiangyi, Hunan, PR China) at 5000×g for 10 
min, the supernatants were discarded, and the bacterial cells 
resuspended in sterile saline solution and adjusted to 109 CFU/
mL. Thus obtained suspensions were applied as inocula for SSF.
Optimization of fermentation conditions using orthogonal 
experimental design 
Table 1 shows the influence factors and level values select-
ed in this study. The orthogonal design helped to analyze the 
performance of the fermented Tartary buckwheat and deter-
mine the level of influence of factors (water ratio, inoculum size, 
time) affecting the total viable counts of the probiotic bacteria.
Table 1. Levels and factors affecting the solid-state fermentation 
(SSF) of Tartary buckwheat (TBW)
Independent variable Factor
Level
1 2 3 4
 
A 1:1.5 1:1.25 1:1 1:0.75
N(inoculum)/(CFU/g) B 5·106 107 5·107 108
t/h C 12 24 36 48
Tartary buckwheat grain substrate (40 g) and sterile distilled 
water were mixed in conical flasks (250 mL; Deschem, Chang-
shu, PR China) in mass per volume ratios as shown in Table 2 
and Table 3, autoclaved (SX-500; Tomy, Fukushima, Japan) at 
121 °C for 20 min, and cooled to 37 °C before the addition of the re-
quired amounts of L. plantarum TK9 or L. paracasei TK1501 start-
er cultures. Fermentation of the inoculated substrates occurred 
at 37 °C in an incubator (SHKE6000-1CE; Thermo Fisher Scientif-
ic, Waltham, MA, USA). Afterwards, samples from the optimal 
combinations were freeze-dried using a DW3 freeze dryer (He-
to-Holten A/S; Allerød, Denmark) and stored at –20 °C for fur-
ther analysis. The native unfermented samples (inoculated with 
the same volume of sterile saline) collected at 0 h were used 
as the negative control. SSF was performed in triplicate. SPSS 
software v. 22.0 (17) was used to perform the statistical analysis.
Determination of the total viable counts
Total viable counts of bacterial cells were assessed accord-
ing to the method described by Zhang et al. (18). The fermented 
Tartary buckwheat (10 g) was homogenized for 15 s in 90 mL 
of sterilized physiological saline (0.85 %) in a blender (JT-C; Jin-
tian, Luohe, PR China). Total viable counts of L. plantarum TK9 
and L. paracasei TK1501 were made using a pour plate method 
and MRS agar (Oxoid) after serial dilution in maximum recov-
ery diluents. Serial dilutions were prepared in sterilized physio-
logical saline and 1 mL of the appropriate dilution was poured 
on plates in triplicate. The poured plates of L. plantarum TK9 
were incubated at 37 °C for (48±2) h. The cultures of L. paracasei 
TK1501 were incubated at 37 °C for (60±2) h. The colonies were 
then counted, and the viable counts were expressed as colony 
forming units per gram (CFU/g) of the sample.
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Preparation of extracts 
The freeze-dried samples from the optimal combination 
in the orthogonal experiment and the negative control were 
ground to a powder using an M20 universal mill (IKA, Staufen, 
Germany). Then, 10 g of the freeze-dried SSF powder were 
extracted with 200 mL of 70 % (by volume) ethanol for 2 h 
in an ultrasonic extractor (KH-600TDV; Hechuang, Kunshan, 
PR China). Afterwards, the samples were centrifuged (Herae-
usTM, MultifugeTM X1R; Thermo Fisher Scientific) at 25 155×g 
and 4 °C for 10 min, and the supernatants were collected. The 
residue was then suspended in 100 mL of 70 % (by volume) 
ethanol, ultrasonicated and centrifuged under the same con-
ditions. The supernatants were combined, filtered through 
Whatman no. 1 paper (GE Healthcare, Chicago, IL, USA) and 
freeze-dried. An aliquot comprising 5 mg of the freeze-dried 
sample was stored at –20 °C and dissolved in 1 mL of phos-
phate buffer (0.1 M, pH=6.8; Sinopharm Chemical Reagent 
Co., Ltd, Shanghai, PR China) immediately before analysis. 
Determination of the total phenolic content 
The total phenolic content (TPC) in the extracts was de-
termined by a modified Folin-Ciocalteu method (19). Brief-
ly, 100 μL of each diluted extract were mixed with 500 μL of 
Folin-Ciocalteu reagent (Sangon Biotech, Shanghai, PR China) 
and 6 mL of distilled water, and shaken for 1 min. Afterwards, 2 
mL of a 15 % (by mass per volume) Na2CO3 (Sinopharm Chem-
ical Reagent Co., Ltd, Shanghai, PR China) solution were added 
to the mixture, shaken once again for 2 min, and the volume 
of the solution was adjusted to 10 mL with distilled water. Fi-
nally, the mixture was incubated in the dark for 2 h at room 
temperature. The absorbance at 750 nm was recorded on an 
InfiniteM200 PRO multifunctional microplate reader (Tecan, 
Männedorf, Switzerland) against a solution without sample as 
blank (100 μL of 70 % ethanol instead of the test samples). A 
standard curve was prepared using gallic acid (Sigma-Aldrich, 
St. Louis, MO, USA): 
 A=0.4789c±0.0303 /1/
where A is the absorbance at 750 nm and c is the concentra-
tion of gallic acid (c=0.2–1 mg/mL, R2=0.9978).
Samples were independently analyzed in triplicate and 
the TPC was expressed as milligrams of gallic acid equivalents 
(GAE) per gram of extract.
Determination of total flavonoid content
Determination of total flavonoid content (TFC) followed a 
published colorimetric method (20) with slight modifications 
Table 2. Orthogonal experimental design of different factor levels 
(values 1-4): the experimental results for factors A, B, C with the meas-










1 1 1 1 1.86·109
2 1 2 2 2.26·109
3 1 3 3 1.95·109
4 1 4 4 1.67·109
5 2 1 2 2.00·109
6 2 2 1 2.17·109
7 2 3 4 1.72·109
8 2 4 3 1.67·109
9 3 1 3 1.76·109
10 3 2 4 1.60·109
11 3 3 1 1.72·109
12 3 4 2 1.89·109
13 4 1 4 1.46·109
14 4 2 3 1.85·109
15 4 3 2 1.62·109
16 4 4 1 1.43·109
K1 7.74 7.08 7.18
K2 7.56 7.88 7.77
K3 6.97 7.01 7.23
K4 6.36 6.66 6.45
k1 1.935 1.77 1.795
k2 1.89 1.97 1.9425 A>C>B
k3 1.7425 1.7525 1.8075
k4 1.59 1.665 1.6125
*Each value in the table represents the mean of N=3, Ki=the sum of 
the corresponding test results when the level factor is i for any factor, 
ki= Ki/4 (4 is the number of levels)
Table 3. Orthogonal experimental design of different factor levels 
(values 1-4): the experimental results for factors A, B, C with the meas-










1 1 1 1 3.20·109
2 1 2 2 3.34·109
3 1 3 3 2.98·109
4 1 4 4 2.68·109
5 2 1 2 2.70·109
6 2 2 1 2.95·109
7 2 3 4 2.47·109
8 2 4 3 2.57·109
9 3 1 3 2.44·109
10 3 2 4 2.77·109
11 3 3 1 2.85·109
12 3 4 2 2.86·109
13 4 1 4 1.72·109
14 4 2 3 2.75·109
15 4 3 2 2.75·109
16 4 4 1 2.35·109
K1 12.2 10.06 11.35
K2 10.69 11.81 11.65
K3 10.92 11.05 10.74
K4 9.57 10.46 9.64
k1 3.05 2.515 2.8375
k2 2.6725 2.9525 2.9125 A>C>B
k3 2.73 2.7625 2.685
k4 2.3925 2.615 2.41
*Each value in the table represents the mean of N=3
L. FENG et al.: Antidiabetic Food from Buckwheat Fermented by Probiotics
July-September 2018 | Vol. 56 | No. 3376
as follows: the mixture contained 0.3 mL NaNO2 (Damao 
Chemical Reagent Factory, Tianjin, PR China) solution (5 %, 
by mass per volume), 0.6 mL AlCl3 (Sinopharm Chemical Rea-
gent Co., Ltd) solution (10 %, by mass per volume), 2 mL NaOH 
(Sinopharm Chemical Reagent Co., Ltd) solution (1 M) and 
1 mL diluted sample solution. The volume of the mixture was 
adjusted to 10 mL with distilled water. After 5 min of incuba-
tion at room temperature, the absorbance at 507 nm was re-
corded with multifunctional microplate reader (InfiniteM200 
PRO; Tecan) against the mixture without sample solution as 
a blank. The TFC was expressed as rutin (Yuanye Biological 
Technology, Shanghai, PR China) equivalents per g of sample 
using the calibration curve of rutin: 
 A=0.636c±0.0388 /2/
where A is the absorbance at 507 nm and c is the concentration 
of rutin (R2=0.9974).
Determination of α-glucosidase inhibition
The α-glucosidase inhibition by the samples was assessed 
according to the method described by Zeng et al. (12) with 
slight modifications. Briefly, the reaction mixture contained 
25 μL of 10 mM p-nitrophenyl-α-d-glucopyranoside (PNPG; 
Sigma-Aldrich) and 25 μL of the sample preincubated at 37 
°C for 10 min. The reaction was initiated by the addition of 50 
μL α-glucosidase solution (0.16 U/mL; Sigma-Aldrich) diluted 
with 0.1 M phosphate buffer, and incubated at 37 °C for 30 
min. The reaction was terminated by adding 100 μL of 0.1 M 
Na2CO3 (Sigma-Aldrich). The enzymatic activity was quanti-
fied based on the measurements of the absorbance of the 
samples at 405 nm on a Multiskan MK3 plate reader (Thermo 
Fisher Scientific). Each test sample was analyzed in technical 
triplicate, and the absorbance values were corrected against 
sample blanks in which α-glucosidase was replaced with 
phosphate buffer. The positive control (α-glucosidase activ-
ity with no inhibitor) and negative control (no α-glucosidase 
activity) were prepared by using phosphate buffer instead of 
the sample or instead of the sample and the α-glucosidase 




Determination of DPP-IV inhibition
Dipeptidyl-peptidase IV (DPP-IV) inhibitory activity was 
assessed according to the method described by Zeng et al. 
(12) with some modifications. Briefly, 25 μL Gly-Pro-p-nitroan-
ilide (6 mM; Sigma-Aldrich) and 25 μL Tartary buckwheat sam-
ple, or 25 μL phosphate buffer saline (PBS; Sigma-Aldrich) as a 
control, were mixed and preincubated at 37 °C for 10 min. The 
reaction was initiated by adding 50 μL DPP-IV from porcine 
kidney (3·10–4 U/L, ≥10 U/mg protein; Sigma-Aldrich) and the 
mixture was incubated at 37 °C for 60 min. The reaction was 
terminated by adding 100 μL of 1 M sodium acetate buff-
er (pH=4.0; Sinopharm Chemical Reagent Co., Ltd), and the 
absorbance of the samples at 405 nm was measured on a 
Multiskan MK3 plate reader (Thermo Fisher Scientific). Each 
sample was analyzed in technical triplicate, and the absorb-
ance values were normalized to sample blanks in which DPP-
-IV was replaced with Tris-HCl buffer (0.1 M, pH=8.0; Solarbio, 
Beijing, PR China). The negative control (no DPP-IV activity) 
and positive control (DPP-IV activity with no inhibitor) were 
prepared by using Tris-HCl buffer (100 mM, pH=8.0; Solar-
bio) instead of the sample or instead of the DPP-IV solution 
and the sample, respectively. Diprotin A (Sigma-Aldrich) was 
used as a standard inhibitor. The DPP-IV inhibition rate was 
calculated using Eq. 3.
RESULTS AND DISCUSSION
Statistical analysis of the results obtained using orthogonal 
experimental design 
The most important factors for consideration in the devel-
opment of functional food are the bioactive components. In 
this study, we developed a probiotic product in a solid-state 
fermentation on Tartary buckwheat, taking into considera-
tion the final viable probiotic cell count. Thus, the fermen-
tation parameters were optimized in order to obtain a high 
growth rate of the lactic acid bacteria (LAB) in Tartary buck-
wheat. We designed an orthogonal experiment with three 
factors and four levels (Table 1). The results served to find the 
optimal fermentation conditions and analyze the relationship 
between the factors and systemic performance of the fer-
mentation (Table 2 and Table 3). Ki represents the sum of 
the corresponding test results when the level number is i for 
any factor (Table 3), and ki=Ki/4 (4 is the number of levels). The 
larger the R value (R=Kmax–Kmin), the greater the influence of this 
factor on the viable count. We found that the R values of the 
water ratio (A), inoculum size (B) and time of fermentation (C) 
for TK9 and TK1501 were R=0.345, 0.305, 0.330 and R=0.6575, 
0.4375, 0.5025, respectively. The effect of the factors on the 
number of viable bacteria was in the order: A>C>B. Thus, the 
optimal fermentation conditions were a 1:1.5 water ratio, a 
24-hour fermentation period and 107 CFU/g inoculum size 
(A1C2B2). Subsequently, analysis of variance (ANOVA) deter-
mined the significance of the model (Table 4 and Table 5). 
The p-values served as a tool to check the significance of each 
coefficient; the lower the p-value, the higher the significance 
of the corresponding coefficient. The corresponding p<0.05 
suggested that the water ratio, inoculum size and time of fer-
mentation are significant terms. Therefore, a small variation 
of their values will notably alter the total viable count. Under 
the optimal conditions, the highest viable counts of Tartary 
buckwheat fermented by L. plantarum TK9 and L. paracasei 
TK1501 were (2.3±0.7)·109 CFU/g and (3.3±0.4)·109 CFU/g, re-
spectively.
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Table 4. Analysis of variance and regression analysis for L. plantar-
um TK9
Source SS df Mean square F P
Water ratio (A) 0.293 3 0.098 7.005 0.02
Inoculum size (B) 0.199 3 0.066 4.763 0.05
Time (C) 0.220 3 0.073 5.266 0.04
Error 0.084 6 0.014
Corrected total 0.796 15
SS=sum of squares, F=variance ratio, P=probability
Table 5. Analysis of variance and regression analysis for L. paracasei 
TK1501
Source SS df Mean square F P
Water ratio (A) 0.873 3 0.291 9. 785 0.01
Inoculum size (B) 0.434 3 0.145 4.870 0.48
Time (C) 0.492 3 0.197 6.631 0.25
Error 0.178 6 0.030
Corrected total 2.077 15
SS=sum of squares, F=variance ratio, P=probability
Total phenolic content during Tartary buckwheat fermentation
During the fermentation of Tartary buckwheat by LAB, the 
composition of the buckwheat changes under the influence 
of bacterial metabolism. Hence, fermentation affected the bio- 
active constituents (Table 6). In Tartary buckwheat extracts, TPC 
(expressed as GAE) increased from (243.0±14.0) mg/g in the 
dry extract of native unfermented sample to (251.8±10.4) mg/g 
in the extract of Tartary buckwheat fermented by L. plantar-
um TK9. The TPC of Tartary buckwheat fermented by L. para-
casei TK1501 was (241.5±5.4) mg/g dry extract, without signif-
icant changes compared to the native unfermented material. 
Zhu (5) and Ran and Ma (21) reported a similar TPC in Tartary 
buckwheat. The possible explanation for these results is that 
the metabolic activity of microbes can modify the levels of bio- 
active compounds during fermentation (22). Some reports stat-
ed that fermentation by L. plantarum is an efficient process for 
increasing the concentration of phenolic compounds in fer-
mented cowpea flour (23,24). The β-glucosidase enzyme pro-
duced during fermentation is thought to catalyze the hydrolysis 
of complex polyphenols to yield simpler and biologically more 
active compounds, leading to an increase of the total phenolic 
content (25). In addition, some reports suggested that the high-
er antioxidant activity might be due to the presence of phenol-
ic components (26).
Table 6. The chemical composition of native unfermented and fer-
mented Tartary buckwheat (TBW)
Sample TPC(as GAE)/(mg/g) TFC/(mg/g) 





TPC=total phenolic content, TFC=total flavonoid content. Each value 
in the table represents the mean±S.D., N=3, p<0.05
Total flavonoid content during Tartary buckwheat 
fermentation
The TFC of the different samples is shown in Table 6. The 
TFC of the native unfermented Tartary buckwheat sample, as 
well as the samples fermented by L. plantarum TK9 and L. para- 
casei TK1501 was (25.5±1.1), (25.6±1.4) and (25.7±0.4) mg/g, 
respectively. No significant differences in the TFC were ob-
servable between the native unfermented Tartary buckwheat 
and the preparations fermented by L. plantarum TK9 and L. 
paracasei TK1501. Importantly, this also means that there was 
no loss of TFC during fermentation. Moreover, recent reports 
stated that the TFC of Tartary buckwheat is much higher than 
that of common buckwheat (12,27).
Inhibition of α-glucosidase activity
Diabetes is a chronic metabolic disorder mainly character-
ized by high blood glucose levels. Therefore, treatment of di-
abetes mainly focuses on reducing the fluctuations of blood 
glucose in order to reduce the subsequent complications. This 
has led to the development of α-glucosidase inhibitors as oral 
anti-diabetic agents, widely used in treatment of diabetes, 
that can postpone the digestion and absorption of carbohy-
drates, and thus reduce postprandial hyperglycaemia (28). In 
this study, the extracts of Tartary buckwheat fermented using 
the two different strains were able to inhibit α-glucosidase in 
a concentration-dependent manner (Fig. 1). All tested Tartary 
buckwheat extracts at a concentration of 1 mg/mL showed 
α-glucosidase inhibitory activities ranging from 29.25 to 75.82 
%, with the higher value obtained using Tartary buckwheat 
fermented by L. plantarum TK9. This extract at 0.008, 0.04, 0.1, 
0.2, 0.4, 0.8 and 1.0 mg/mL displayed α-glucosidase inhibi-
tory activities of (0.03±0.02), (0.3±0.2), (2.3±0.4), (20.2±1.6), 
(42.8±0.3), (68.91±0.05) and (75.8±0.2) %, respectively, with an 
IC50 value of 0.51 mg/mL. By contrast, the extract of native Tar-
tary buckwheat at the same concentrations had inhibitory ac-
tivities of (1.5±7.8), (4.9±1.6), (5.7±4.0), (17.8±2.2), (22.6±1.5), 
(44.1±1.3) and (60.5±0.6) %, respectively, with an IC50 value 
0.87 mg/mL. The extract fermented with L. paracasei TK1501 
Fig. 1. α-Glucosidase inhibition activity by Tartary buckwheat (TBW) 
ethanol extracts obtained in solid-state fermentation. Each value 
corresponds to the mean of three independent replicates with error 
bars indicating the standard deviations
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was even less effective, with respective inhibitory activities of 
(2.7±5.9), (5.7±3.7), (7.2±1.6), (7.1±1.6), (10.4±5.7), (17.1±7.0) 
and (29.2±0.5) %, with an IC50 value >1 mg/mL. The IC50 value 
of the positive control (acarbose) for α-glucosidase inhibition 
was 0.85 mg/mL (26). Earlier studies have reported that Tartary 
buckwheat inhibits α-glucosidase (29). Based on the relation-
ship between bioactive components and α-glucosidase inhi-
bition, TFC and TPC are considered to play an important role in 
the inhibitory activity of Tartary buckwheat (21). Some reports 
have suggested that many flavonoids can inhibit α-glucosidase 
activity (30). Moreover, quercetin has a higher inhibitory activ-
ity on α-glucosidase than rutin (4). Therefore, we suspected 
that the L. plantarum TK9 fermentation enhanced the querce-
tin content. It has already been confirmed that certain strains 
of Lactobacillus have inhibitory potential against a range of 
α-glucosidases and at least one β-glucosidase (31). It was found 
that a product fermented by L. plantarum TK9 has a significantly 
higher inhibitory effect on α-glucosidase than that by L. paraca-
sei TK1501. The inhibition of intestinal α-glucosidase is a known 
strategy to regulate blood glucose (32). Although synthetic in-
hibitors of intestinal α-glucosidase have found wide application 
in the clinic, there are considerations concerning cost and side 
effects. Consequently, there is a demand for alternatives from 
natural plant, animal and probiotic sources (33–35), and many 
bacteria have been shown to have inhibitory activity. Cell-free 
supernatants of six strains of L. plantarum showed inhibitory ac-
tivity ranging from 24.96 to 41.81 % (36). Notably, the strain TK9 
investigated in this study was even more active than these six 
strains. Its comparatively high inhibitory activity suggests that 
Tartary buckwheat fermented by L. plantarum TK9 may have 
dual beneficial effects on glycaemia regulation by reducing the 
intestinal absorption of carbohydrates. Similarly, reports have 
shown that L. plantarum NCU116 and carrot juice fermented 
by it had the potential to regulate blood glucose levels (37). 
The Tartary buckwheat fermented by L. plantarum TK9 had very 
satisfactory α-glucosidase inhibitory activity, and it merits com-
mercial exploration as an efficient agent for the management 
of glucose metabolism.
Inhibition of DPP-IV activity
Dipeptidyl peptidase IV (DPP-IV) is a highly specialized ami-
nopeptidase that appears to be a major physiological modu-
lator of a number of regulatory peptides, neuropeptides and 
chemokines (38,39). GLP-1 is a gastrointestinal hormone that 
can reduce appetite, suppress glucagon secretion, stimulate 
insulin secretion and reduce gastric emptying (13). Reports 
show that GLP-1 levels reduced after a mixed meal and an oral 
glucose load in patients with diabetes type 2 (40). The enzyme 
DPP-IV rapidly metabolizes GLP-1 (41). Preliminary clinical data 
have shown the potential of DPP-IV inhibitors in treating diabe-
tes type 2 (42). The need to develop safe DPP-IV inhibitors has 
led to increased attention to natural sources. Recently, natu-
ral sources as diverse as dietary proteins, medicinal plants, 
and marine life have been confirmed to have DPP-IV inhibito-
ry effects (43). All extracts used in our research showed DPP-IV 
inhibitory activity in a concentration-dependent manner. The 
Tartary buckwheat extracts (4 mg/mL) showed DPP-IV inhibito-
ry potential, among which the extract of Tartary buckwheat fer-
mented by L. paracasei TK1501 displayed the greatest inhibition 
(77.2±1.9) %, followed by L. plantarum TK9 (57.3±2.1) % and 
native non-fermented Tartary buckwheat extract (39.9±1.4) %. 
Fig. 2 shows the inhibitory effects of the three different Tartary 
buckwheat samples (native, fermented by L. plantarum TK9 and 
L. paracasei TK1501) at different concentrations (0.2–5 mg/mL), 
with IC50>5, 3.45 and 2.47 mg/mL, respectively. Unlike the re-
sults of α-glucosidase inhibition, the extract of Tartary buck-
wheat fermented by L. paracasei TK1501 showed the best in-
hibition of DPP-IV activity. The positive control diprotin A had 
an IC50 of 1.15 mg/mL, and behaved as a competitive inhibitor, 
which was in agreement with the literature (12,21). Our work 
represents the first report on the inhibition of DPP-IV activity 
by Tartary buckwheat. We speculated that effective inhibito-
ry components might not be related to TPC or TFC in view of 
our previous results. Similarly, some reports suggest that the 
strains themselves were the most likely producer of the inhib-
itory compounds (1,12,21,44). The results of this study suggest 
that fermented Tartary buckwheat has antihyperglycaemic 
properties, and hence might provide a new dietotherapy food 
for the control of diabetes. 
Fig. 2. Dipeptidyl peptidase IV (DPP-IV) inhibition activity by Tartary 
buckwheat (TBW) ethanol extracts obtained in solid-state fermenta-
tion (SSF). Each value corresponds to the mean of three independent 
replicates with error bars indicating the standard deviations
CONCLUSIONS
This study evaluated the chemical composition and anti-
oxidant and antihyperglycaemic activities of two Tartary buck-
wheat samples fermented using pure cultures of Lactobacil-
lus plantarum TK9 and L. paracasei TK1501, respectively, and 
compared them to native unfermented Tartary buckwheat. 
There was little difference in the total phenolic and total flavo-
noid contents between the fermented and native unferment-
ed Tartary buckwheat. Moreover, the extracts of Tartary buck-
wheat fermented by L. plantarum TK9 and L. paracasei TK1501 
showed remarkable α-glucosidase and dipeptidyl peptidase 
IV inhibitory effects, respectively. Taken together, the data 
Food Technol. Biotechnol. 56 (3) 373-380 (2018)
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indicate good potential of fermented Tartary buckwheat for 
application in the production of antidiabetic functional foods.
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